1-20 of 137
Authors: A Jain
Save search
Sort by
Journal Article

SUN-623 Androgen Receptor Expression in Men With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Open Access

PDF
A Goffinet and others
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.2344, https://doi.org/10.1210/jendso/bvae163.2344
Published: 29 April 2025
Journal Article

A233 CANADIAN EXPERIENCE OF ENDOSCOPIC ULTRASOUND-GUIDED GALLBLADDER DRAINAGE: A CASE SERIES Open Access

PDF
S X Jiang and others
Journal of the Canadian Association of Gastroenterology, Volume 8, Issue Supplement_1, February 2025, Pages i96–i97, https://doi.org/10.1093/jcag/gwae059.233
Published: 10 February 2025
Journal Article

7275 Diverse Reasons for Discontinuing Gender Affirming Hormone Therapy Open Access

PDF
A Jain and M S Irwig
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.1586, https://doi.org/10.1210/jendso/bvae163.1586
Published: 05 October 2024
Journal Article

7659 Iodinated Contrast Induced Thyrotoxicosis Leading to Takotsubu Cardiomyopathy Open Access

PDF
A Jain and others
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.1989, https://doi.org/10.1210/jendso/bvae163.1989
Published: 05 October 2024
Journal Article

P-334 TITLE: NATIONAL POLICY INDEX (NPI) FOR WORKER MENTAL HEALTH AND ITS RELATIONSHIP WITH ENTERPRISE PSYCHOSOCIAL SAFETY CLIMATE Free

PDF
R Potter and others
Occupational Medicine, Volume 74, Issue Supplement_1, July 2024, Page 0, https://doi.org/10.1093/occmed/kqae023.0941
Published: 03 July 2024
Journal Article

A306 A CASE OF SCLEROSING CHOLANGITIS AS A COMPLICATION OF CAR-T THERAPY Open Access

PDF
B Zhao and others
Journal of the Canadian Association of Gastroenterology, Volume 7, Issue Supplement_1, March 2024, Pages 249–250, https://doi.org/10.1093/jcag/gwad061.306
Published: 14 February 2024
Journal Article

P637 Ozanimod efficacy with or without concomitant corticosteroids in 5-ASA–exposed, advanced therapy–naive, immunomodulator-naive patients with ulcerative colitis: a post hoc analysis of True North Free

PDF
S Horst and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1211–i1212, https://doi.org/10.1093/ecco-jcc/jjad212.0767
Published: 24 January 2024
Journal Article

P1009 Efficacy and safety of 4 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study Free

PDF
G D'Haens and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1814–i1815, https://doi.org/10.1093/ecco-jcc/jjad212.1139
Published: 24 January 2024
Journal Article

DOP78 Efficacy of ozanimod by patient response trajectory subgroups identified using group-based trajectory modelling: a post hoc analysis of the phase 3 True North study Free

PDF
S W Schreiber and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i216–i217, https://doi.org/10.1093/ecco-jcc/jjad212.0118
Published: 24 January 2024
Journal Article

P567 Impact of recent thiopurine use on ozanimod safety in patients with ulcerative colitis: a post hoc analysis of the phase 3 True North study Free

PDF
R Battat and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1100–i1101, https://doi.org/10.1093/ecco-jcc/jjad212.0697
Published: 24 January 2024
Journal Article

DOP16 Safety of long-term ozanimod treatment for up to 4 years in patients with moderately to severely active Ulcerative Colitis: an interim analysis of the True North open-label extension Free

PDF
C Siegel and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i100–i101, https://doi.org/10.1093/ecco-jcc/jjad212.0056
Published: 24 January 2024
Journal Article

P545 Long-term efficacy of ozanimod up to 3 years in patient response subgroups identified using group-based trajectory modelling Free

PDF
S W Schreiber and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1067–i1068, https://doi.org/10.1093/ecco-jcc/jjad212.0675
Published: 24 January 2024
Journal Article

P789 Impact of risk factors for Janus kinase inhibitor use identified by the Pharmacovigilance Risk Assessment Committee on the safety and efficacy of ozanimod in patients with moderately to severely active ulcerative colitis Free

PDF
B Siegmund and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1461–i1463, https://doi.org/10.1093/ecco-jcc/jjad212.0919
Published: 24 January 2024
Journal Article

Usefulness of Neutrophil-to-Lymphocyte Ratio (NLR) in predicting adverse outcomes in adult patients with heart failure : A systematic review and meta analysis Free

PDF
A Mondal and others
European Heart Journal, Volume 44, Issue Supplement_2, November 2023, ehad655.879, https://doi.org/10.1093/eurheartj/ehad655.879
Published: 09 November 2023
Journal Article

Burden and predictors of subsequent/recurrent stroke, associated sex/racial disparities and in-hospital outcomes in elderly patients with obstructive sleep apnea and prior stroke/TIA Free

PDF
S Singh and others
European Journal of Preventive Cardiology, Volume 30, Issue Supplement_1, June 2023, zwad125.223, https://doi.org/10.1093/eurjpc/zwad125.223
Published: 24 May 2023
Journal Article

Prevalence and risk of type 2 myocardial infarction (T2MI) in adults with depression and its impact on in-hospital outcomes: a nationwide population-based analysis in the USA (2019) Free

PDF
B Brereton and others
European Journal of Preventive Cardiology, Volume 30, Issue Supplement_1, June 2023, zwad125.231, https://doi.org/10.1093/eurjpc/zwad125.231
Published: 24 May 2023
Journal Article

DOP39 Endoscopic, histologic, and combined outcomes with reinitiation of ozanimod after temporary discontinuation: 2-year interim analysis of the True North open-label extension study Free

PDF
S Vermeire and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i103–i104, https://doi.org/10.1093/ecco-jcc/jjac190.0079
Published: 30 January 2023
Journal Article

P464 Effects of ozanimod on histologic remission and mucosal healing over 3 years of continuous treatment in patients with ulcerative colitis Free

PDF
R Panaccione and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i591–i593, https://doi.org/10.1093/ecco-jcc/jjac190.0594
Published: 30 January 2023
Journal Article

P719 Symptomatic improvement and long-term stability of ulcerative colitis symptoms over 3 years of ozanimod treatment Free

PDF
S Danese and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i848–i850, https://doi.org/10.1093/ecco-jcc/jjac190.0849
Published: 30 January 2023
Journal Article

DOP37 Efficacy and safety of 3 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study Free

PDF
S Danese and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i101–i102, https://doi.org/10.1093/ecco-jcc/jjac190.0077
Published: 30 January 2023